What Does Selexis SA Do?

Total employees29
HeadquartersPlan-les-Ouates
Founded2001

Selexis SA is a pioneering life sciences company specializing in mammalian cell line development for the biopharmaceutical industry. Their proprietary SUREtechnology Platform™ and KEEPER® and CHO-Mcell® technologies enable the rapid, stable, and cost-effective generation of high-performance cell lines for producing therapeutic proteins and vaccines. Acquired by JSR Corporation in 2017, Selexis is now an integral part of JSR Life Sciences, contributing significantly to the 'molecule-to-market' services offered by the group. They partner with biotech and pharmaceutical companies globally to accelerate the development and manufacturing of complex biologics.

Where Is Selexis SA's Headquarters?

Selexis SA officeSelexis SA officeSelexis SA officeSelexis SA office
*Images sourced via web search. Rights belong to original owners

HQ Function

The headquarters serves as the primary center for research and development, cell line development operations, global business development, and corporate administration.

Notable Features:

The facility houses state-of-the-art laboratories equipped for advanced cell line engineering, development, and characterization, supporting their proprietary technology platforms.

Work Culture:

The work culture at Selexis SA is characterized by scientific rigor, innovation, collaboration, and a strong focus on quality and customer success, reflecting both Swiss precision and the dynamic nature of the biotech industry.

HQ Significance:

Its location in the Geneva biotech cluster provides access to a rich talent pool, research collaborations, and proximity to many European pharmaceutical partners.

Values Reflected in HQ: The headquarters reflects Selexis's commitment to cutting-edge science, precision, efficiency, and providing high-value solutions to the biopharmaceutical industry.

Location:

Selexis SA serves a global clientele from its base in Switzerland, with its reach and capabilities significantly amplified by being part of JSR Life Sciences. JSR Life Sciences supports functions globally, including business development, customer service, GMP manufacturing (through KBI Biopharma and other JSR entities), and strategic partnerships across North America, Europe, and Asia-Pacific. This network enables Selexis to offer its specialized cell line development services to pharmaceutical and biotech companies worldwide, facilitating seamless project integration from early development through to commercial manufacturing.

Street Address:

Chemin des Aulx 14

City:

Plan-les-Ouates

State/Province:

Geneva

Country:

Switzerland

Where Else Does Selexis SA Operate Around the World?

Global (via JSR Life Sciences)

Address: Selexis SA primarily operates from its Geneva headquarters. Global reach and support are provided through JSR Life Sciences, which has significant operations in regions including North America (e.g., Sunnyvale, CA, USA; Research Triangle Park, NC, USA for KBI Biopharma) and Asia-Pacific (e.g., Tokyo, Japan; Shanghai, China).

To provide localized support, engage with regional clients, and integrate Selexis's expertise into JSR Life Sciences' comprehensive 'molecule-to-market' solutions for the global biopharmaceutical industry.

Buying Intent Signals for Selexis SA

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Who's Leading Selexis SA? Meet the Executive Team

As of April 2025, Selexis SA' leadership includes:

Dirk Lange - Chief Executive Officer, Selexis SA & President/CEO, KBI Biopharma (JSR Life Sciences Companies)
Regine Brokamp - Chief Operating Officer
Roland Hecht - Chief Business Officer
Pierre-Alain Girod - Chief Scientific Officer

Who's Investing in Selexis SA?

Selexis SA has been backed by several prominent investors over the years, including:

JSR Corporation (Parent Company since 2017)

What Leadership Changes Has Selexis SA Seen Recently?

Hire0
Exits0

Publicly available information does not indicate significant executive hires or exits specifically at Selexis SA in the immediate last 12 months. Leadership changes within the broader JSR Life Sciences group may occur and indirectly impact Selexis SA. For example, Mark W. Womack transitioned from CEO of JSR Life Sciences to an advisory role in early 2024, with Tim Lowery appointed as his successor (effective April 2024), which is a change at the parent company level.

Departures

Mark W. Womack, Mark W. Womack transitioned from his role as CEO of JSR Life Sciences to an advisory position.

New Appointments:

Tim Lowery, Tim Lowery appointed as President and CEO of JSR Life Sciences, the parent organization of Selexis SA.

What Technology (Tech Stack) Is Used bySelexis SA?

Discover the tools Selexis SA uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

Selexis SA Email Formats and Examples

Selexis SA, as part of JSR Life Sciences, likely uses standardized professional email formats. The most common formats for companies of this nature are [first_initial][last]@[companydomain.com] or [first].[last]@[companydomain.com]. Given their integration, some communications might also originate from or be directed to jsrlifesciences.com email addresses.

[first_initial][last]@selexis.com (e.g., jsmith@selexis.com) or [first].[last]@selexis.com (e.g., john.smith@selexis.com)

Format

dlange@selexis.com

Example

80%

Success rate

What's the Latest News About Selexis SA?

JSR Life Sciences NewsFebruary 7, 2024

JSR Life Sciences to Appoint Tim Lowery as President and CEO

JSR Corporation announced that Tim Lowery will be appointed President and CEO of JSR Life Sciences, effective April 1, 2024. Mark Womack, current CEO, will transition to an advisory role. This leadership change affects the parent company of Selexis SA....more

Business WireSeptember 13, 2023

Selexis SA and GigaGen Inc. Sign Service Agreement to Advance GigaGen’s Pipeline of Novel Antibody Therapeutics

Selexis SA, a JSR Life Sciences company, and GigaGen Inc., a subsidiary of Grifols, announced they have signed a service agreement. Selexis will leverage its SUREtechnology Platform™ to advance GigaGen's diverse pipeline of recombinant polyclonal antibody therapeutics....more

Selexis SA Press ReleaseMay 9, 2023

Selexis SA and SpyBiotech Enter Service Agreement for Development of Novel Vaccine Candidate

Selexis SA and SpyBiotech Ltd announced they have entered into a service agreement to develop the cell line for SpyBiotech’s novel vaccine candidate targeting human cytomegalovirus (HCMV), based on SpyBiotech’s proprietary Hepatitis B surface antigen (HBsAg) virus-like particle (VLP) platform technology....more

Highperformr's free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including Selexis SA, are just a search away.